Acquired Company
Pathos AI Completes Acquisition of Rain Oncology
Rain Enhancement Technologies Holdco, Inc. develops, improves, and commercializes atmospheric enhancement by ionization (AEI) technology. It plans to develop improvements on existing rainfall generation technologies by introducing robust measurement tools, including software monitoring technology, machine learning, rain gauges, and weather stations. The company was founded in 2022 and is headquartered in Naples, Florida. Show more
4851 Tamiami Trail N, Naples, FL, 34103, United States
Market Cap
16.96M
52 Wk Range
$1.26 - $8.52
Previous Close
$1.58
Open
$1.60
Volume
9,439
Day Range
$1.55 - $1.72
Enterprise Value
27.95M
Cash
580.6K
Avg Qtr Burn
-1.874M
Insider Ownership
68.54%
Institutional Own.
9.44%
Qtr Updated
03/31/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Milademetan (RAIN-32) w/ atezolizumab Details Solid tumor/s, Cancer | Failed Discontinued | |
Milademetan (Rain-32) Details Solid tumor/s, Cancer, Carcinoma , Metastatic merkel cell carcinoma | Failed Discontinued | |
Milademetan (Rain-32) Details Liposarcoma, Cancer, Solid tumor/s | Failed Discontinued | |
Milademetan (RAIN-32) Details Solid tumor/s, Cancer | Failed Discontinued |
